Laboratory:Akiruno

Laboratory:Akiruno
TEST NAME |
SPECIMEN REQUIREMENT (mL) |
CONTAINER | CAP COLOR | STORE TEMPERATURE (STABILITY) |
TURNAROUND TIME (DAY) |
METHODOLOGY | REFERENCE RANGE (UNIT) |
---|---|---|---|---|---|---|---|
|
Unstained specimen slide
5 to 10 sheets thickness 5μm |
Z10 |
![]() |
8-14 |
Multiplex PCR-fragment analysis |
||
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
17-21 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
17-21 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
Methylation PCR |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
17-21 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
17-21 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
5.0 |
PN5 |
![]() |
![]() (3 days) |
30-90 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (7 days) |
47-65 |
Next Generation Sequencing (NGS) |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() |
12-23 |
MLPA |
No gene deletions or duplications observed |
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
PCR |
Not allowed to insert |
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
19-23 | Multiplex PCR-fragment analysis | |
|
Blood (EDTA-2Na added)
5.0 |
PN5 |
![]() |
![]() (10 days) |
35-80 |
Next Generation Sequencing (NGS) |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
28-35 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
17-21 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
PCR |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
PCR |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
7-11 | PCR-rSSO method | |
|
Blood (EDTA-2Na added)
7.0 |
PN7 |
![]() |
![]() (3 days) |
Please contact us in advance. |
Next Generation Sequencing (NGS) |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
3-9 | PCR-rSSO method | |
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() |
12-16 |
gFCS |
No mutations detected |
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() |
12-16 |
gFCS |
No mutations detected |
TEST NAME |
SPECIMEN REQUIREMENT (mL) |
CONTAINER | CAP COLOR | STORE TEMPERATURE (STABILITY) |
TURNAROUND TIME (DAY) |
METHODOLOGY | REFERENCE RANGE (UNIT) |
---|---|---|---|---|---|---|---|
|
Unstained specimen slide
5 to 10 sheets thickness 5μm |
Z10 |
![]() |
8-14 |
Multiplex PCR-fragment analysis |
||
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
17-21 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
17-21 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
Methylation PCR |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
17-21 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
17-21 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
5.0 |
PN5 |
![]() |
![]() (3 days) |
30-90 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (7 days) |
47-65 |
Next Generation Sequencing (NGS) |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() |
12-23 |
MLPA |
No gene deletions or duplications observed |
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
PCR |
Not allowed to insert |
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
19-23 | Multiplex PCR-fragment analysis | |
|
Blood (EDTA-2Na added)
5.0 |
PN5 |
![]() |
![]() (10 days) |
35-80 |
Next Generation Sequencing (NGS) |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
28-35 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
17-21 |
Direct sequence method |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
PCR |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
12-16 |
PCR |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
7-11 | PCR-rSSO method | |
|
Blood (EDTA-2Na added)
7.0 |
PN7 |
![]() |
![]() (3 days) |
Please contact us in advance. |
Next Generation Sequencing (NGS) |
|
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() (3 days) |
3-9 | PCR-rSSO method | |
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() |
12-16 |
gFCS |
No mutations detected |
|
Blood (EDTA-2Na added)
2.0 |
PN2,PN5 |
![]() |
![]() |
12-16 |
gFCS |
No mutations detected |